Item 9 Labs (INLB)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Aug 5, 2024 03:29 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
INLB 0.00 0.00(0.00%)
Will INLB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INLB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INLB
Item 9 Labs Corp. (INLB) Reports Q3 Loss, Misses Revenue Estimates
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates
INLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
OraSure Technologies (OSUR) Reports Break-Even Earnings for Q2
Other News for INLB
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers